BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38632341)

  • 21. Improvement in predicting tumorigenic phenotype of androgen-insensitive human LNCaP prostatic cancer cell subline in recombination with rat urogenital sinus mesenchyme.
    Kanai M; Ishii K; Kanda H; Ogura Y; Kise H; Arima K; Sugimura Y
    Cancer Sci; 2008 Dec; 99(12):2435-43. PubMed ID: 19018772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth and characterization of LNCaP prostate cancer cell spheroids.
    Ballangrud AM; Yang WH; Dnistrian A; Lampen NM; Sgouros G
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3171s-3176s. PubMed ID: 10541360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor.
    Eder IE; Hoffmann J; Rogatsch H; Schäfer G; Zopf D; Bartsch G; Klocker H
    Cancer Gene Ther; 2002 Feb; 9(2):117-25. PubMed ID: 11857028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orthotopic tumorgrafts in nude mice: A new method to study human prostate cancer.
    Saar M; Körbel C; Linxweiler J; Jung V; Kamradt J; Hasenfus A; Stöckle M; Unteregger G; Menger MD
    Prostate; 2015 Oct; 75(14):1526-37. PubMed ID: 26074274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP Cells.
    Thalmann GN; Rhee H; Sikes RA; Pathak S; Multani A; Zhau HE; Marshall FF; Chung LW
    Eur Urol; 2010 Jul; 58(1):162-71. PubMed ID: 19747763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
    Zeng Y; Opeskin K; Goad J; Williams ED
    Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time whole-body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent protein.
    Yang M; Jiang P; Yamamoto N; Li L; Geller J; Moossa AR; Hoffman RM
    Prostate; 2005 Mar; 62(4):374-9. PubMed ID: 15389802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer.
    Sasaki T; Ishii K; Iwamoto Y; Kato M; Miki M; Kanda H; Arima K; Shiraishi T; Sugimura Y
    Lab Invest; 2016 Mar; 96(3):338-49. PubMed ID: 26641067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosterone.
    Jennbacken K; Gustavsson H; Tesan T; Horn M; Vallbo C; Welén K; Damber JE
    Prostate; 2009 Aug; 69(11):1164-75. PubMed ID: 19399749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells.
    Wilson MJ; Sinha AA
    Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells.
    McGovern JA; Bock N; Shafiee A; Martine LC; Wagner F; Baldwin JG; Landgraf M; Lahr CA; Meinert C; Williams ED; Pollock PM; Denham J; Russell PJ; Risbridger GP; Clements JA; Loessner D; Holzapfel BM; Hutmacher DW
    Commun Biol; 2021 Aug; 4(1):1014. PubMed ID: 34462519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
    Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
    Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous metastasis of PC-3 cells in athymic mice after implantation in orthotopic or ectopic microenvironments.
    Waters DJ; Janovitz EB; Chan TC
    Prostate; 1995 May; 26(5):227-34. PubMed ID: 7753708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
    Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
    Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis.
    Downing S; Bumak C; Nixdorf S; Ow K; Russell P; Jackson P
    Mol Carcinog; 2003 Nov; 38(3):130-40. PubMed ID: 14587098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible model of spheroid formation allows for high efficiency of gene delivery ex vivo and accurate gene assessment in vivo.
    Alpaugh ML; Barsky SH
    Hum Gene Ther; 2002 Jul; 13(10):1245-58. PubMed ID: 12133277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
    Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
    Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
    Thalmann GN; Sikes RA; Chang SM; Johnston DA; von Eschenbach AC; Chung LW
    J Natl Cancer Inst; 1996 Jun; 88(12):794-801. PubMed ID: 8637045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model.
    Kovar JL; Johnson MA; Volcheck WM; Chen J; Simpson MA
    Am J Pathol; 2006 Oct; 169(4):1415-26. PubMed ID: 17003496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.